was read the article
array:24 [ "pii" => "S2173572719300979" "issn" => "21735727" "doi" => "10.1016/j.medine.2019.05.005" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "1300" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2019;43:302-16" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2188 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 1866 "PDF" => 262 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0210569118303358" "issn" => "02105691" "doi" => "10.1016/j.medin.2018.12.002" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "1300" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2019;43:302-16" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5960 "formatos" => array:3 [ "EPUB" => 98 "HTML" => 4233 "PDF" => 1629 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">DOCUMENTO DE CONSENSO</span>" "titulo" => "Documento práctico del manejo de la hiponatremia en pacientes críticos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "302" "paginaFinal" => "316" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Practical document on the management of hyponatremia in critically ill patients" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1861 "Ancho" => 3167 "Tamanyo" => 346771 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Algoritmo diagnóstico de la hiponatremia.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.J. Broch Porcar, B. Rodríguez Cubillo, J.M. Domínguez-Roldán, L. Álvarez Rocha, M.Á. Ballesteros Sanz, M. Cervera Montes, M. Chico Fernández, J.H. de Gea García, P. Enríquez Giraudo, A. García de Lorenzo y Mateos, R. Gómez López, R. Guerrero Pavón, F. López Sánchez, J.A. Llompart-Pou, S. Lubillo Montenegro, Z. Molina Collado, P. Ramírez Galleymore, M. Riveiro Vilaboa, A. Sánchez Corral, M.E. Herrera-Gutiérrez" "autores" => array:20 [ 0 => array:2 [ "nombre" => "M.J." "apellidos" => "Broch Porcar" ] 1 => array:2 [ "nombre" => "B." "apellidos" => "Rodríguez Cubillo" ] 2 => array:2 [ "nombre" => "J.M." "apellidos" => "Domínguez-Roldán" ] 3 => array:2 [ "nombre" => "L." "apellidos" => "Álvarez Rocha" ] 4 => array:2 [ "nombre" => "M.Á." "apellidos" => "Ballesteros Sanz" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Cervera Montes" ] 6 => array:2 [ "nombre" => "M." "apellidos" => "Chico Fernández" ] 7 => array:2 [ "nombre" => "J.H." "apellidos" => "de Gea García" ] 8 => array:2 [ "nombre" => "P." "apellidos" => "Enríquez Giraudo" ] 9 => array:2 [ "nombre" => "A." "apellidos" => "García de Lorenzo y Mateos" ] 10 => array:2 [ "nombre" => "R." "apellidos" => "Gómez López" ] 11 => array:2 [ "nombre" => "R." "apellidos" => "Guerrero Pavón" ] 12 => array:2 [ "nombre" => "F." "apellidos" => "López Sánchez" ] 13 => array:2 [ "nombre" => "J.A." "apellidos" => "Llompart-Pou" ] 14 => array:2 [ "nombre" => "S." "apellidos" => "Lubillo Montenegro" ] 15 => array:2 [ "nombre" => "Z." "apellidos" => "Molina Collado" ] 16 => array:2 [ "nombre" => "P." "apellidos" => "Ramírez Galleymore" ] 17 => array:2 [ "nombre" => "M." "apellidos" => "Riveiro Vilaboa" ] 18 => array:2 [ "nombre" => "A." "apellidos" => "Sánchez Corral" ] 19 => array:2 [ "nombre" => "M.E." "apellidos" => "Herrera-Gutiérrez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173572719300979" "doi" => "10.1016/j.medine.2019.05.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572719300979?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118303358?idApp=WMIE" "url" => "/02105691/0000004300000005/v2_201906050809/S0210569118303358/v2_201906050809/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173572719300888" "issn" => "21735727" "doi" => "10.1016/j.medine.2018.10.007" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "1284" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Intensiva. 2019;43:317-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 424 "formatos" => array:3 [ "EPUB" => 64 "HTML" => 261 "PDF" => 99 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Preliminary results of the ADENI-ICU trial: Analysis of decisions of refuse admission in intensive care units as a limitation of life support treatments; multi-center, prospective, observational study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "317" "paginaFinal" => "319" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Resultados preliminares del estudio ADENI-UCI: análisis de las decisiones de no ingreso en unidades de cuidados intensivos como medida de limitación de los tratamientos de soporte vital; estudio multicéntrico, prospectivo y observacional" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Escudero-Acha, M. Palomo Navarro, O. Leizaola Irigoyen, B. Vidal Tegedor, D. González Romero, M. Misis del Campo, P. Recena Pérez, M.C. Pavía Pesquera, S. Freita Ramos, G. Miró Andreu, A.M. de Pablo Hermida, M. Barceló Castelló, M.L. Blasco Cortes, D. Ballesteros Ortega, N. Lázaro Martín, D. Díaz Díaz, M. Pérez Ruiz, R. Poyo-Guerrero, M. Cordero Vallejo, O. Acune, J. Duerto Alvarez, M.C. Garcia Torrejon, E.M. Gómez Gómez, L. Claverías Cabreras, I. Gomez Acebo, A. Gonzalez-Castro" "autores" => array:27 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Escudero-Acha" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Palomo Navarro" ] 2 => array:2 [ "nombre" => "O." "apellidos" => "Leizaola Irigoyen" ] 3 => array:2 [ "nombre" => "B." "apellidos" => "Vidal Tegedor" ] 4 => array:2 [ "nombre" => "D." "apellidos" => "González Romero" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Misis del Campo" ] 6 => array:2 [ "nombre" => "P." "apellidos" => "Recena Pérez" ] 7 => array:2 [ "nombre" => "M.C." "apellidos" => "Pavía Pesquera" ] 8 => array:2 [ "nombre" => "S." "apellidos" => "Freita Ramos" ] 9 => array:2 [ "nombre" => "G." "apellidos" => "Miró Andreu" ] 10 => array:2 [ "nombre" => "A.M." "apellidos" => "de Pablo Hermida" ] 11 => array:2 [ "nombre" => "M." "apellidos" => "Barceló Castelló" ] 12 => array:2 [ "nombre" => "M.L." "apellidos" => "Blasco Cortes" ] 13 => array:2 [ "nombre" => "D." "apellidos" => "Ballesteros Ortega" ] 14 => array:2 [ "nombre" => "N." "apellidos" => "Lázaro Martín" ] 15 => array:2 [ "nombre" => "D." "apellidos" => "Díaz Díaz" ] 16 => array:2 [ "nombre" => "M." "apellidos" => "Pérez Ruiz" ] 17 => array:2 [ "nombre" => "R." "apellidos" => "Poyo-Guerrero" ] 18 => array:2 [ "nombre" => "M." "apellidos" => "Cordero Vallejo" ] 19 => array:2 [ "nombre" => "O." "apellidos" => "Acune" ] 20 => array:2 [ "nombre" => "J." "apellidos" => "Duerto Alvarez" ] 21 => array:2 [ "nombre" => "M.C." "apellidos" => "Garcia Torrejon" ] 22 => array:2 [ "nombre" => "E.M." "apellidos" => "Gómez Gómez" ] 23 => array:2 [ "nombre" => "L." "apellidos" => "Claverías Cabreras" ] 24 => array:2 [ "nombre" => "I." "apellidos" => "Gomez Acebo" ] 25 => array:2 [ "nombre" => "A." "apellidos" => "Gonzalez-Castro" ] 26 => array:1 [ "colaborador" => "Bioethics Working Group of the SEMICYUC" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0210569118302833" "doi" => "10.1016/j.medin.2018.10.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118302833?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572719300888?idApp=WMIE" "url" => "/21735727/0000004300000005/v1_201906010831/S2173572719300888/v1_201906010831/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173572719300906" "issn" => "21735727" "doi" => "10.1016/j.medine.2019.04.003" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "1271" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Intensiva. 2019;43:299-301" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 407 "formatos" => array:3 [ "EPUB" => 76 "HTML" => 215 "PDF" => 116 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Point of view</span>" "titulo" => "Reducing the use of physical restraints, a pending and emerging matter at the ICU" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "299" "paginaFinal" => "301" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La reducción del uso de contenciones mecánicas, una asignatura pendiente y emergente en las UCI" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1754 "Ancho" => 2500 "Tamanyo" => 265656 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Reflective model on the use of physical restraint measures.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">PAD: pain/agitation/delirium.</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Adapted from Via-Clavero et al. Ethical-legal and clinical considerations on the use of restraining measures. Official College of Nurses of Barcelona (<span class="elsevierStyleItalic">Col·legi Oficial d’Infermeres i Infermers de Barcelona</span> [COIB]). Pending publication.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Acevedo-Nuevo, G. Via-Clavero" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Acevedo-Nuevo" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Via-Clavero" ] 2 => array:1 [ "colaborador" => "Grupo de Trabajo Analgesia, Sedación, Contenciones y Delirio de la Sociedad Española de Enfermería Intensiva y Unidades Coronarias" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0210569118302663" "doi" => "10.1016/j.medin.2018.09.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118302663?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572719300906?idApp=WMIE" "url" => "/21735727/0000004300000005/v1_201906010831/S2173572719300906/v1_201906010831/en/main.assets" ] "en" => array:22 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus statement</span>" "titulo" => "Practical document on the management of hyponatremia in critically ill patients" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "302" "paginaFinal" => "316" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M.J. Broch Porcar, B. Rodríguez Cubillo, J.M. Domínguez-Roldán, L. Álvarez Rocha, M.Á. Ballesteros Sanz, M. Cervera Montes, M. Chico Fernández, J.H. de Gea García, P. Enríquez Giraudo, A. García de Lorenzo y Mateos, R. Gómez López, R. Guerrero Pavón, F. López Sánchez, J.A. Llompart-Pou, S. Lubillo Montenegro, Z. Molina Collado, P. Ramírez Galleymore, M. Riveiro Vilaboa, A. Sánchez Corral, M.E. Herrera-Gutiérrez" "autores" => array:20 [ 0 => array:4 [ "nombre" => "M.J." "apellidos" => "Broch Porcar" "email" => array:1 [ 0 => "ixuscorreu@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "B." "apellidos" => "Rodríguez Cubillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "J.M." "apellidos" => "Domínguez-Roldán" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "L." "apellidos" => "Álvarez Rocha" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "M.Á." "apellidos" => "Ballesteros Sanz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "M." "apellidos" => "Cervera Montes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "M." "apellidos" => "Chico Fernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "J.H." "apellidos" => "de Gea García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "P." "apellidos" => "Enríquez Giraudo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 9 => array:3 [ "nombre" => "A." "apellidos" => "García de Lorenzo y Mateos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">j</span>" "identificador" => "aff0050" ] ] ] 10 => array:3 [ "nombre" => "R." "apellidos" => "Gómez López" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">k</span>" "identificador" => "aff0055" ] ] ] 11 => array:3 [ "nombre" => "R." "apellidos" => "Guerrero Pavón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">l</span>" "identificador" => "aff0060" ] ] ] 12 => array:3 [ "nombre" => "F." "apellidos" => "López Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">m</span>" "identificador" => "aff0065" ] ] ] 13 => array:3 [ "nombre" => "J.A." "apellidos" => "Llompart-Pou" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">n</span>" "identificador" => "aff0070" ] ] ] 14 => array:3 [ "nombre" => "S." "apellidos" => "Lubillo Montenegro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">o</span>" "identificador" => "aff0075" ] ] ] 15 => array:3 [ "nombre" => "Z." "apellidos" => "Molina Collado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 16 => array:3 [ "nombre" => "P." "apellidos" => "Ramírez Galleymore" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 17 => array:3 [ "nombre" => "M." "apellidos" => "Riveiro Vilaboa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">p</span>" "identificador" => "aff0080" ] ] ] 18 => array:3 [ "nombre" => "A." "apellidos" => "Sánchez Corral" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">q</span>" "identificador" => "aff0085" ] ] ] 19 => array:3 [ "nombre" => "M.E." "apellidos" => "Herrera-Gutiérrez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">r</span>" "identificador" => "aff0090" ] ] ] ] "afiliaciones" => array:18 [ 0 => array:3 [ "entidad" => "Unidad de Medicina Intensiva, Hospital Universitario y Politécnico La Fe, Valencia, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Universitario Clínico San Carlos, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario A Coruña, A Coruña, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Dr. Peset, Valencia, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos de Trauma y Emergencias, Servicio de Medicina Intensiva, Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Río Hortega, Valladolid, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain" "etiqueta" => "j" "identificador" => "aff0050" ] 10 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Quirónsalud Miguel, Pontevedra, Spain" "etiqueta" => "k" "identificador" => "aff0055" ] 11 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Universitario Reina Sofía, Córdoba, Spain" "etiqueta" => "l" "identificador" => "aff0060" ] 12 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital General Universitario de Alicante, Alicante, Spain" "etiqueta" => "m" "identificador" => "aff0065" ] 13 => array:3 [ "entidad" => "Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma de Mallorca, Spain" "etiqueta" => "n" "identificador" => "aff0070" ] 14 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain" "etiqueta" => "o" "identificador" => "aff0075" ] 15 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos de Traumatología, Hospital Universitario Vall d’Hebrón, Barcelona, Spain" "etiqueta" => "p" "identificador" => "aff0080" ] 16 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Universitario Vall d’Hebrón, Barcelona, Spain" "etiqueta" => "q" "identificador" => "aff0085" ] 17 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Regional Universitario Carlos Haya, Málaga, Spain" "etiqueta" => "r" "identificador" => "aff0090" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Documento práctico del manejo de la hiponatremia en pacientes críticos" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1861 "Ancho" => 3390 "Tamanyo" => 333731 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Hyponatremia diagnostic algorithm.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Hyponatremia (HN) is the most frequent electrolytic disorder in the Intensive Care Unit (ICU). It therefore seems reasonable to develop a document addressing HN in the critical patient from a practical perspective. Two important guides have been published to date,<a class="elsevierStyleCrossRefs" href="#bib0480"><span class="elsevierStyleSup">1,2</span></a> though some of their recommendations are not applicable to the critically ill due to the type of disease involved and the severity of the patient condition (e.g., water restriction in neurocritical patients).<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">3</span></a> Furthermore, the guides present controversial points particularly as refers to treatment, since the American guides indicate vaptans for the management of euvolemic and hypervolemic HN, while the European guides do not indicate them in any case.<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The present study was therefore carried out to offer a practical review of useful aspects in dealing with HN in Spanish ICUs, with the aim of clarifying, homogenizing and providing a common algorithm for the management of this disorder.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Methodology used to produce the document</span><p id="par0015" class="elsevierStylePara elsevierViewall">Drafting of this document was proposed by its coordinators, and it was developed by a group of Spanish intensivists chosen by the coordinators, with experience in the management of critical patients in different scenarios (neurocritical, cardiac, postsurgical, hepatic and multiple disorders), and forming part of the different working groups of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (<span class="elsevierStyleItalic">Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias</span> [SEMICYUC]), in collaboration with <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>. The document received the scientific endorsement of the SEMICYUC.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The document was developed on the basis of three phases and meetings. The first meeting involved presentation of the questions raised by the coordinators to the members of the group of specialists. The items were discussed, and consensus was reached among all the members, with assignment of the questions among the participants. It was agreed that each question should be reviewed by two experts, and the literature was distributed following an initial global search conducted by the coordinators. This search comprised a PubMed review of the available scientific literature (in English and in Spanish) covering the period from 1 January 2000 to 31 December 2017, and including observational studies (prospective and retrospective), clinical trials, meta-analyses and reviews. Those studies not involving humans were initially excluded. The literature search terms used were hyponatremia «and»: <span class="elsevierStyleItalic">algorithm, classification, critical care, diagnosis, differential diagnosis, etiology, euvolemia, heart failure, hypervolemia, hypovolemia, incidence, liver cirrhosis, neurocritical care, physiopathology, prognosis, recommendations, syndrome of inappropriate ADH (antidiuretic hormone) secretion, surgery, symptoms, treatment, vasopressin, vaptans, wasting salt syndrome.</span></p><p id="par0025" class="elsevierStylePara elsevierViewall">Posteriorly, and according to the criterion of each expert, additional references were selected and added based on the abovementioned articles or following a second literature search where considered necessary.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The second meeting was used to submit the answers, define the key concepts related to each question, and introduce the opportune changes based on consensus among all the experts. The last meeting in turn served to discuss the writing and extent of the draft, which was reviewed and approved by all the signing participants.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Thus, the conclusions and practical recommendations of this document are largely fundamented upon the experience and opinions of the authors, and supported by a comprehensive review of the current literature.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Definition of hyponatremia</span><p id="par0040" class="elsevierStylePara elsevierViewall">Hyponatremia is defined as a plasma sodium concentration ([Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>) of under 135<span class="elsevierStyleHsp" style=""></span>mEq/l.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">5</span></a> However, the risk threshold for starting treatment depends on the background disease involved. In this respect, the threshold in neurocritical patients is considered to be [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>140<span class="elsevierStyleHsp" style=""></span>mEq/l,<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">6</span></a> versus [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>130<span class="elsevierStyleHsp" style=""></span>mEq/l<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">7</span></a> in patients with liver failure, and [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>130<span class="elsevierStyleHsp" style=""></span>mEq/l<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">8</span></a> in patients with heart failure.</p><p id="par0045" class="elsevierStylePara elsevierViewall">It is important to take into account that the clinical diagnosis in the critical patient is more difficult to establish than in other scenarios, due to the previous treatments and background disease involved. Furthermore, HN in these patients may present with clinical manifestations similar to those of the disorders giving rise to hyponatremia.<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">9</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Incidence and prognosis of hyponatremia in the critical patient</span><p id="par0050" class="elsevierStylePara elsevierViewall">In hospitalized patients, the incidence of HN is close to 30% (when defined as <135<span class="elsevierStyleHsp" style=""></span>mEq/l),<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">10</span></a> but it is difficult to establish the impact of HN in the ICU, due to the scarcity of studies made with this purpose in mind. In any case, the reported incidence is between 12 and 34%, depending on the series (<a class="elsevierStyleCrossRef" href="#sec0155">Table S1 of supplementary material</a>). Although there are studies that have evaluated the association between HN and hospital stay, quality of life or mortality, quality issues prevent us from establishing whether there is a causal relationship or not (<a class="elsevierStyleCrossRef" href="#sec0155">Table S1 of supplementary material</a>). Different hypotheses have been proposed to explain the association, such as the notion that the high mortality rate observed among hospitalized patients with HN could be more an expression of the severity of the background disease than of the direct impact of HN as such – since patients with extremely low sodium values present lesser mortality.<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">11</span></a> Another hypothesis is that very low plasma sodium values are detected earlier, and are therefore quickly treated, whereas sodium values in a more moderate range might be regarded as unimportant – thereby resulting in delayed treatment that may worsen the morbidity–mortality figures.<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">12</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Physiopathology of hyponatremia</span><p id="par0055" class="elsevierStylePara elsevierViewall">From the physiopathological perspective, subtle increments in osmotic pressure (Osm<span class="elsevierStyleInf">p</span>) (1–2%) are detected by the hypothalamic osmoreceptors, which in turn stimulate the thirst center, with the synthesis of antidiuretic hormone (ADH) or vasopressin-arginine.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">5</span></a> This hormone acts upon the collecting tubules, and water is reabsorbed via the type 2 aquaporins (AQ2) (water channels) to normalize Osm<span class="elsevierStyleInf">p</span> (280–296<span class="elsevierStyleHsp" style=""></span>mOsm/kg)<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">13</span></a> and increase urine concentration. There are other stimuli more potent than Osm<span class="elsevierStyleInf">p</span> that also release ADH (e.g., a decrease in effective circulating volume [ECV], stress, pain, nausea or drugs<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">14</span></a>). In this way, dilute urine (osmolality<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>100<span class="elsevierStyleHsp" style=""></span>mOsm/kg) with low urinary potassium and sodium ([Na<span class="elsevierStyleSup">+</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>) is indicative of the inhibition ADH.<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">15</span></a> The simultaneous determination of the plasma and urinary concentration of Na<span class="elsevierStyleSup">+</span>, K<span class="elsevierStyleSup">+</span> and of osmolality, as well as the estimation of total body water and volemia, are key elements for establishing the etiology of HN. <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> provides an orientative summary of the most common clinical scenarios and the behavior of the parameters that help to distinguish them, though some cases may differ from those described (diuretics) or may not be interpretable (renal failure).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Neurological repercussions of hyponatremia</span><p id="par0060" class="elsevierStylePara elsevierViewall">Acute HN can cause brain edema as a consequence of the osmotic gradient generated by hypoosmolarity and that causes water to penetrate into the glial cells.<a class="elsevierStyleCrossRef" href="#bib0555"><span class="elsevierStyleSup">16</span></a> There are mechanisms allowing the brain to adapt to HN (outflux of inorganic ions [K<span class="elsevierStyleSup">+</span> and Cl<span class="elsevierStyleSup">−</span>]<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">17</span></a> thanks to the Na-K-ATPase pump<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">18</span></a> and of osmotic metabolites), and which come into effect in the presence of HN for over 48<span class="elsevierStyleHsp" style=""></span>h,<a class="elsevierStyleCrossRefs" href="#bib0570"><span class="elsevierStyleSup">19–21</span></a> reducing the brain edema.<a class="elsevierStyleCrossRef" href="#bib0585"><span class="elsevierStyleSup">22</span></a> Some individuals are characterized by poorer adaptation to HN,<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">23</span></a> such as women of child-bearing age and patients with hypoxemia, since estrogens and hypoxemia block the Na-K-ATPase pump, preventing water outflux from the intracellular compartment.<a class="elsevierStyleCrossRef" href="#bib0595"><span class="elsevierStyleSup">24</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">On the other hand, having established the brain adaptation mechanisms, rapid correction of HN would give rise to a hypertonic extracellular environment<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">15</span></a> that can cause cell dehydration and structural neuronal damage<a class="elsevierStyleCrossRefs" href="#bib0600"><span class="elsevierStyleSup">25,26</span></a> known as cerebral osmotic demyelination syndrome (ODS) – the consequences of which can range from attention deficit to coma and death.<a class="elsevierStyleCrossRefs" href="#bib0610"><span class="elsevierStyleSup">27,28</span></a> Factors favoring the development of ODS are malnutrition, hypopotassemia, alcoholism, cirrhosis and very low natremia levels, among others.<a class="elsevierStyleCrossRefs" href="#bib0480"><span class="elsevierStyleSup">1,29</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Practical concepts referred to the critical patient with hyponatremia</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Question one. How is hyponatremia classified?</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Practical recommendations</span><p id="par0070" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">•</span><p id="par0075" class="elsevierStylePara elsevierViewall">Hyponatremia can be classified according to natremia, tonicity, volemia, symptoms and/or speed of onset.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">•</span><p id="par0080" class="elsevierStylePara elsevierViewall">It is considered important to individualize the risk threshold of [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> according to the patient clinical context in order to start treatment.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">•</span><p id="par0085" class="elsevierStylePara elsevierViewall">It is preferable to assume as <span class="elsevierStyleItalic">chronic</span> any presentation of hyponatremia if we do not know its speed of onset.</p></li></ul></p><p id="par0090" class="elsevierStylePara elsevierViewall">Due to the complexity of the critical patient with hyponatremia, its classification should be based on a series of concepts – the most widely used being natremia,<a class="elsevierStyleCrossRef" href="#bib0625"><span class="elsevierStyleSup">30</span></a> tonicity,<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">13</span></a> volemia,<a class="elsevierStyleCrossRefs" href="#bib0630"><span class="elsevierStyleSup">31,32</span></a> symptoms<a class="elsevierStyleCrossRef" href="#bib0640"><span class="elsevierStyleSup">33</span></a> and/or speed of onset <a class="elsevierStyleCrossRefs" href="#bib0585"><span class="elsevierStyleSup">22,34</span></a>(<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">We must discard possible pseudohyponatremia or isotonic HN,<a class="elsevierStyleCrossRef" href="#bib0650"><span class="elsevierStyleSup">35</span></a> which constitutes a laboratory artifact found in the presence of high blood lipid or protein concentrations, where a relative increase is detected in the solid phase of plasma that can be avoided by using direct selective ion flux techniques.<a class="elsevierStyleCrossRef" href="#bib0650"><span class="elsevierStyleSup">35</span></a> On the other hand, when plasma contains osmotically active particles (hyperglycemia, mannitol, sorbitol or contrast media) that increase plasma tonicity, water leaves the intracellular compartment, reducing [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>. These are cases of hypertonic HN known as HN.<a class="elsevierStyleCrossRef" href="#bib0655"><span class="elsevierStyleSup">36</span></a> It is important to detect these scenarios, since specific treatment is only required in the case of hypotonic or hypoosmolar HN.</p><p id="par0100" class="elsevierStylePara elsevierViewall">One of the most important classifications is based on the presence or absence of symptoms.</p><p id="par0105" class="elsevierStylePara elsevierViewall">The current tendency is to consider that all HN presentations have symptoms, though these may go unnoticed because they are very subtle or are masked by the background disease process, particularly in elderly patients, where an increased incidence of falls, osteoporosis, attention deficits, fractures and gait instability have been documented.<a class="elsevierStyleCrossRef" href="#bib0660"><span class="elsevierStyleSup">37</span></a> However, in the critical patient, it is still practical to consider HN as either symptomatic or asymptomatic according to the presence or absence of neurological symptoms, which are the factors deciding the urgency of treatment.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The risk threshold for starting the treatment of hyponatremia depends on the background disease and the clinical context – the criterion being more strict in the case of neurocritical patients.<a class="elsevierStyleCrossRefs" href="#bib0490"><span class="elsevierStyleSup">3,38,39</span></a> If the speed of onset is not known, and there are no serious neurological symptoms attributable to HN, it is preferable to assume the latter as being chronic, in order to minimize the risk of ODS.<a class="elsevierStyleCrossRefs" href="#bib0595"><span class="elsevierStyleSup">24,40</span></a></p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Question two. What is the importance of volemia evaluation in the hyponatremic critical patient?</span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Practical recommendations</span><p id="par0115" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">•</span><p id="par0120" class="elsevierStylePara elsevierViewall">Try to obtain an approximate and precise assessment of volemia in the patient with hyponatremia in order to secure a correct etiological diagnosis.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">•</span><p id="par0125" class="elsevierStylePara elsevierViewall">Combine different methods for the evaluation of volemia and the obtainment of a differential diagnosis of hyponatremia.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">•</span><p id="par0130" class="elsevierStylePara elsevierViewall">Avoid using only clinical criteria for assessing total body water and ECV in the critical patient, particularly in distinguishing between normo- versus hypovolemic patients.</p></li></ul></p><p id="par0135" class="elsevierStylePara elsevierViewall">Patients with HN can present hypo-, normo- or hypervolemia.<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">31</span></a> In the critical patient, precise assessment of volemia and body water is very complex, and analytical or clinical parameters<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">32</span></a> alone are not enough, since several causes of HN may coexist, along with specific factors that alter the exploration. In order to obtain a global view and avoid potential errors, a comprehensive evaluation is advisable – not only parametric assessment of volemia – taking into account the clinical elements, time course and volemia estimators. Traditionally, extracellular volume has been used as a reflection of ECV, and has been the parameter evaluated first in order to obtain a physiopathological interpretation.<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">9</span></a> However, ECV is the variable that conditions the mechanisms that favor the development of HN, and is therefore the key to correct diagnosis. In this document we use the terms ECV (effective circulating volume or volemia) versus total body water in order to lessen ambiguity. The estimation of ECV is not easy<a class="elsevierStyleCrossRefs" href="#bib0680"><span class="elsevierStyleSup">41–44</span></a> and requires both the evaluation of clinical aspects and the use of instrumental methods (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). The estimation is more complex when edematous conditions coexist with low and ineffective ECV (congestive heart failure, nephrotic syndrome or cirrhosis), since these scenarios are characterized by stimulation of the non-osmotic secretion of ADH and of the renin-angiotensin-aldosterone system,<a class="elsevierStyleCrossRef" href="#bib0700"><span class="elsevierStyleSup">45</span></a> with the consequent decrease in excretion of free water and the appearance of HN.<a class="elsevierStyleCrossRef" href="#bib0705"><span class="elsevierStyleSup">46</span></a><a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> details the methods available for assessing effective volemia, though we are aware of the difficulties involved. Although the clinical history is crucial, in cases of doubt we can use hemodynamic monitoring to complement the diagnosis, though caution is required when using this strategy in the context of HN.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Question three. What are the natremia correction and monitoring objectives in hyponatremic patients?</span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Practical recommendations</span><p id="par0140" class="elsevierStylePara elsevierViewall">General objectives of the treatment of HN<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">•</span><p id="par0145" class="elsevierStylePara elsevierViewall">Adjust the treatment of HN to the severity of the symptoms, the duration of the condition, and the underlying cause and physiopathology.</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">•</span><p id="par0150" class="elsevierStylePara elsevierViewall">Prescribe individualized treatment based on the risk of over-correction versus the risk of brain edema.</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">•</span><p id="par0155" class="elsevierStylePara elsevierViewall">Start treatment early in the case of acute or severe HN.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">•</span><p id="par0160" class="elsevierStylePara elsevierViewall">Avoid inadequately rapid correction of natremia, since structural neurological damage may result.</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">•</span><p id="par0165" class="elsevierStylePara elsevierViewall">Avoid the use of HN correction formulas, due to the high risk of over-correction.</p></li></ul></p><p id="par0170" class="elsevierStylePara elsevierViewall">Specific objectives of treatment. Monitoring of HN<ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">•</span><p id="par0175" class="elsevierStylePara elsevierViewall">Optimize oxygenation and correct the potassium levels as part of the hyponatremia management plan.</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">•</span><p id="par0180" class="elsevierStylePara elsevierViewall">Avoid the use of hypotonic fluids in the event of severe or symptomatic HN.</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">•</span><p id="par0185" class="elsevierStylePara elsevierViewall">Use 3% hypertonic saline solution (HSS) when the symptoms are severe and adjust its administration to the weight of the patient (0.5–2<span class="elsevierStyleHsp" style=""></span>ml/kg) according to the desired correction rate.</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">•</span><p id="par0190" class="elsevierStylePara elsevierViewall">Follow a treatment and monitoring protocol that combines natremia elevation with ideal correction time.</p></li><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">•</span><p id="par0195" class="elsevierStylePara elsevierViewall">Monitor the treatment of HN with data referred to Na+ in blood and urine.</p></li></ul></p><p id="par0200" class="elsevierStylePara elsevierViewall">In treating HN it is essential to take a series of general objectives into account, considering each case, in order to avoid delays in management or excessively rapid correction of the condition.<a class="elsevierStyleCrossRefs" href="#bib0580"><span class="elsevierStyleSup">21,34,47–49</span></a></p><p id="par0205" class="elsevierStylePara elsevierViewall">Individualization allows us to adopt a short- to middle-term management protocol that adequately combines natremia elevation and ideal correction time (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>). Likewise, monitoring of the critical patient with HN must be suited to the established management plans.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0210" class="elsevierStylePara elsevierViewall">We consider that hypoxemia and hypopotassemia must be taken into account in the management plan, as patients with hyponatremia and hypoxemia have a poorer prognosis,<a class="elsevierStyleCrossRef" href="#bib0595"><span class="elsevierStyleSup">24</span></a> since hypoxemia can alter solute extrusion by blocking the Na-K-ATPase pump and thus delay the resolution of brain edema.<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">50</span></a> Likewise, there have been reports of ODS with slow natremia correction in patients with hypopotassemia. In this regard, it has been speculated that the reduced Na-K-ATPase pump concentration in the endothelial membrane in situations of hypopotassemia may predispose to neuron damage due to the osmotic stress associated to the correction of natremia.<a class="elsevierStyleCrossRefs" href="#bib0730"><span class="elsevierStyleSup">51,52</span></a></p><p id="par0215" class="elsevierStylePara elsevierViewall">With regard to specific treatment, we can use an infusion of 3% HSS in boluses or in perfusion.<a class="elsevierStyleCrossRefs" href="#bib0505"><span class="elsevierStyleSup">6,45,53</span></a></p><p id="par0220" class="elsevierStylePara elsevierViewall">While a common practice, the use of formulas for calculating the correction of natremia may prove hazardous due to the high risk of over-correction or the provision of large volumes that would be prohibitive in patients with heart failure.<a class="elsevierStyleCrossRef" href="#bib0745"><span class="elsevierStyleSup">54</span></a> These formulas regard the patient as a closed system and ignore the renal response of the subject to such infusion – thereby possibly offering inexact information.<a class="elsevierStyleCrossRef" href="#bib0750"><span class="elsevierStyleSup">55</span></a></p></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Question four. What is the most appropriate treatment for hyponatremic patients according to the type of natremia involved?</span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Practical recommendations</span><p id="par0225" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">•</span><p id="par0230" class="elsevierStylePara elsevierViewall">Use 3% HSS in hyponatremic encephalopathy, independently of the cause.</p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">•</span><p id="par0235" class="elsevierStylePara elsevierViewall">Administer 0.9% saline solution (SS) in hypovolemic HN, with close monitoring of aquaresis (water excretion without electrolyte loss) in order to avoid over-correction.</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">•</span><p id="par0240" class="elsevierStylePara elsevierViewall">Treat the triggering cause of hypervolemic HN.</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">•</span><p id="par0245" class="elsevierStylePara elsevierViewall">Vaptans can be used in hypervolemic HN refractory to first line treatment.</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">•</span><p id="par0250" class="elsevierStylePara elsevierViewall">Do not use vaptans in severe or hypovolemic HN.</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">•</span><p id="par0255" class="elsevierStylePara elsevierViewall">Diuretics can be used as adjuvant treatment in hypervolemic and normovolemic HN.</p></li></ul></p><p id="par0260" class="elsevierStylePara elsevierViewall">For the correction of HN we can use water restriction (WR), NaCl capsules, saline solution (normal or hypertonic),<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">21</span></a> diuretics (furosemide), urea, vaptans and fludrocortisone.<a class="elsevierStyleCrossRefs" href="#bib0480"><span class="elsevierStyleSup">1,2,9,56</span></a> The choice of one treatment or other should be based on the underlying cause and physiopathology, the desired correction rate, and the associated comorbidities (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>). Loop diuretics may be useful as coadjuvants to the treatments started in euvolemic or hypervolemic HN.<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">56</span></a></p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0265" class="elsevierStylePara elsevierViewall">The vaptans, as V2 receptor antagonists, increase free water excretion, reducing Osm<span class="elsevierStyleInf">u</span> and incrementing natremia.<a class="elsevierStyleCrossRef" href="#bib0760"><span class="elsevierStyleSup">57</span></a> In 2006, two randomized clinical trials known as the Study of Ascending Levels of Tolvaptan in hyponatremia (SALT-1 and SALT-2) respectively compared the efficacy of tolvaptan versus placebo in 225 and 223 patients with euvolemic and hypervolemic HN – the latter being severe in at least 50% of the cases in both cohorts. These studies reported an increase in serum sodium concentration from the start until day 4 of treatment, and from the start until day 30 in all the patients treated with an initial daily dose of 15<span class="elsevierStyleHsp" style=""></span>mg, which could be incremented conditioned to the observed increase in serum sodium.<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">58</span></a> In Spain, tolvaptan has only been approved for the management of syndrome of inappropriate antidiuretic hormone secretion (SIADH)<a class="elsevierStyleCrossRef" href="#bib0770"><span class="elsevierStyleSup">59</span></a> refractory to first line therapeutic measures, despite the scant supporting evidence, or when such measures cannot be implemented.<a class="elsevierStyleCrossRef" href="#bib0775"><span class="elsevierStyleSup">60</span></a> It is advisable to start the treatment in the hospital setting and not to simultaneously apply WR or administer 3% HSS, due to the risk of over-correction. For this same reason, adequate fluid supply must be ensured in patients with alterations of the thirst mechanism (intubated or sedated individuals).</p><p id="par0270" class="elsevierStylePara elsevierViewall">We consider that it might be of benefit to reduce the starting dose to 7.5<span class="elsevierStyleHsp" style=""></span>mg in critical patients. In some cases the administration of a single dose has been evaluated, followed by the decision to either repeat administration or introduce continuous therapy (off-label use not contemplated in the Summary of Product Characteristics).<a class="elsevierStyleCrossRef" href="#bib0780"><span class="elsevierStyleSup">61</span></a> If correction is too fast, the drug will have to be suspended, or the dose will have to be lowered. Reported side effects have been thirst, pollakiuria, dehydration or orthostatic hypotension.<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">58</span></a></p><p id="par0275" class="elsevierStylePara elsevierViewall">The hypervolemic hyponatremia usually seen in patients with heart failure, liver cirrhosis and nephrotic syndrome requires specific treatment of the background disease, which among other aspects will help to increase free water clearance and thus improve HN. However, some patients are refractory to such treatment, and although vaptans are not indicated in Spain for hyponatremia of this kind, in some cases they may be used on an off-label basis. In this regard, in patients with heart failure, the joint administration of tolvaptan and standard treatment for heart failure – including loop diuretics – was seen to result in short term improvement of the global situation and of HN, though without benefits in terms of mortality.<a class="elsevierStyleCrossRefs" href="#bib0785"><span class="elsevierStyleSup">62,63</span></a> Likewise, patients with decompensated liver cirrhosis and refractory ascites showed a good response to tolvaptan, with an increase in urine volume and natremia, and improvement of ascites.<a class="elsevierStyleCrossRef" href="#bib0795"><span class="elsevierStyleSup">64</span></a></p><p id="par0280" class="elsevierStylePara elsevierViewall">Hypovolemic hyponatremia is characterized by the depletion of extracellular volume, and the administration of 0.9% saline solution suffices to correct this situation.<a class="elsevierStyleCrossRef" href="#bib0800"><span class="elsevierStyleSup">65</span></a> Vaptans would not be indicated in this type of HN or in acute symptomatic HN. The latter requires urgent management to increase natremia, and the indication in this context is 3% HSS, for although there are no data in the literature supporting the use of vaptans in this type of HN, the onset of tolvaptan action occurs after 2<span class="elsevierStyleHsp" style=""></span>h, and we therefore would not obtain the immediate effect we seek.</p><p id="par0285" class="elsevierStylePara elsevierViewall">Tolvaptan likewise has no indication in patients with hypothyroidism or adrenal gland insufficiency.<a class="elsevierStyleCrossRef" href="#bib0805"><span class="elsevierStyleSup">66</span></a></p></span></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Question five. Is it important to study the causes of secondary syndrome of inappropriate antidiuretic hormone secretion in the critical patient?</span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Practical recommendations</span><p id="par0290" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">•</span><p id="par0295" class="elsevierStylePara elsevierViewall">Study the causes that may trigger secondary SIADH, and consider that primary SIADH is an exclusion based diagnosis.</p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">•</span><p id="par0300" class="elsevierStylePara elsevierViewall">In order to diagnose SIADH, the following criteria must be met: [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>135<span class="elsevierStyleHsp" style=""></span>mEq/l, Osm<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>275<span class="elsevierStyleHsp" style=""></span>mOsm/kg, Osm<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>100<span class="elsevierStyleHsp" style=""></span>mOsm/kg, [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>mmol/l with adequate Na<span class="elsevierStyleSup">+</span> supply, glomerular filtration rate (GFR)<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>60<span class="elsevierStyleHsp" style=""></span>ml/min, normal thyroid and adrenal gland function, euvolemia, absence of diuretics and absence of physiological ADH stimulation (surgery, pain, thoracic, lung or brain involvement).</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">•</span><p id="par0305" class="elsevierStylePara elsevierViewall">A diagnosis of SIADH without correct assessment of secondary causes may result in an incorrect diagnosis and inadequate treatment.</p></li></ul></p><p id="par0310" class="elsevierStylePara elsevierViewall">Syndrome of inappropriate antidiuretic hormone secretion occurs due to non-physiological ADH release (in the pituitary gland or on an ectopic basis) or as a result of increased ADH activity secondary to genetic alterations of its receptors. Antidiuretic hormone reduces the renal excretion of free water with normal excretion of Na<span class="elsevierStyleSup">+</span>, giving rise to euvolemic hypoosmolar HN. The causes of SIADH include neoplasms, central nervous system (CNS) disorders, lung disease, drugs, and transient and genetic factors (mutation of the V2 receptor gene).</p><p id="par0315" class="elsevierStylePara elsevierViewall">Although the diagnostic criteria of SIADH have been clearly defined, it is important to remember that the diagnosis is established on an exclusion basis, and that the first step is to confirm the existence of normovolemia – something that may prove very difficult in the critical patient. The second step is to check that all the validated biochemical criteria are met, and we know that this is not done in routine practice. A recent Italian study has reported that less than half of the surveyed physicians used such parameters to establish the diagnosis.<a class="elsevierStyleCrossRef" href="#bib0810"><span class="elsevierStyleSup">67</span></a> Furthermore, in patients with subarachnoid hemorrhage, it has been seen that 70% of all situations of normovolemic HN are attributable to SIADH and 10% to cortisol defects<a class="elsevierStyleCrossRef" href="#bib0815"><span class="elsevierStyleSup">68</span></a> – hence the importance of remembering that we must have all the criteria in order to establish a correct diagnosis, since the approach to therapy will differ accordingly.</p></span></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Question six. What is the appropriate treatment for correcting hyponatremia in patients with SIADH?</span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Practical recommendations</span><p id="par0320" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">•</span><p id="par0325" class="elsevierStylePara elsevierViewall">Avoid using of WR, urea, lithium or demeclocycline for the treatment of SIADH.</p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">•</span><p id="par0330" class="elsevierStylePara elsevierViewall">Vaptans can be used for the treatment of SIADH when water restriction is not feasible and there are no serious neurological symptoms.</p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">•</span><p id="par0335" class="elsevierStylePara elsevierViewall">Natremia should be checked 6–8<span class="elsevierStyleHsp" style=""></span>h after the administration of vaptans, in order to adequately adjust the next doses.</p></li></ul></p><p id="par0340" class="elsevierStylePara elsevierViewall">The treatment of SIADH should start by controlling the physiological stimuli that release ADH. Water restriction and the supply of solutes (NaCl capsules, proteins) are to be considered in patients with mild symptoms or a chronic syndrome onset,<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">56</span></a> while the administration of 3% HSS can be decided in cases of severe symptoms and an acute syndrome onset .<a class="elsevierStyleCrossRef" href="#bib0820"><span class="elsevierStyleSup">69</span></a></p><p id="par0345" class="elsevierStylePara elsevierViewall">Water restriction remains the first line of treatment in the recently published guides on the management of HN due to SIADH, despite the recognized lack of randomized controlled trials demonstrating its efficacy or safety. The results of a hyponatremia registry showed fluid restriction to be no better than no treatment in patients with SIADH.<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">70</span></a> Furthermore, in critical patients, WR is difficult to apply, since fluids, intravenous antibiotics or nutritional support are essential in such cases. Likewise, several days are usually needed in order for the measure to prove effective, and WR is poorly tolerated and not effective in all patients. The American guides<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">1</span></a> have documented a series of parameters that can predict a poor response to WR: high Osm<span class="elsevierStyleInf">u</span> (>500<span class="elsevierStyleHsp" style=""></span>mOsm/kg), diuresis<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>1500<span class="elsevierStyleHsp" style=""></span>ml/day [Na<span class="elsevierStyleSup">+</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> and a slow natremia correction rate (<2<span class="elsevierStyleHsp" style=""></span>mEq/l in 24–48<span class="elsevierStyleHsp" style=""></span>h).<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">13</span></a></p><p id="par0350" class="elsevierStylePara elsevierViewall">Although urea has repeatedly been proposed as a treatment for HN due to SIADH, the supporting evidence is far from convincing, since the existing studies are few and heterogeneous, nonrandomized, with variable doses and administration intervals, and treatment has been studied in chronic HN.<a class="elsevierStyleCrossRef" href="#bib0830"><span class="elsevierStyleSup">71</span></a> Likewise, the correction afforded by urea is unpredictable and can be associated with dehydration or over-correction, with increased plasma urea levels. Adequate experience with the use of urea is not available, and its administration therefore cannot be recommended. The same applies to lithium or demeclocycline, since the response obtained is variable, unpredictable, and the risk of renal toxicity is high. A recent systematic review found no evidence on their safety and efficacy,<a class="elsevierStyleCrossRef" href="#bib0835"><span class="elsevierStyleSup">72</span></a> and only 3% of the physician used them in SIADH.<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">70</span></a> The use of these drugs therefore cannot be recommended.<a class="elsevierStyleCrossRef" href="#bib0840"><span class="elsevierStyleSup">73</span></a></p><p id="par0355" class="elsevierStylePara elsevierViewall">Loop diuretics in SIADH may be useful over the short term provided Osm<span class="elsevierStyleInf">u</span> is high (preferably<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>400<span class="elsevierStyleHsp" style=""></span>mOsm/kg), by increasing free water clearance through the kidneys. However, we lack randomized studies supporting their use. Such drugs could be administered in patients with transient SIADH (i.e., secondary to pneumonia or drugs that can be suspended).<a class="elsevierStyleCrossRef" href="#bib0775"><span class="elsevierStyleSup">60</span></a></p><p id="par0360" class="elsevierStylePara elsevierViewall">The vaptans, as V2 receptor antagonists, appear to be a logical treatment option in SIADH, since on binding to these receptors AQ2 is not inserted in the collecting tubule, thereby increasing free water clearance or aquaresis. The SALT studies<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">58</span></a> have demonstrated the effectiveness of tolvaptan in increasing natremia in a cohort of mixed patients (SIADH, hypervolemic HN) versus placebo even one month after treatment. The vaptans usually increase natremia by 5–7<span class="elsevierStyleHsp" style=""></span>mEq/l at 24<span class="elsevierStyleHsp" style=""></span>h post-administration, though the effect is variable. In this regard, the European guides do not indicate vaptan use in any type of HN – one of the stated reasons being the fact that the randomized clinical trials made have been sponsored by the drug industry. Although this is a serious consideration in medicine based on evidence, in our opinion it is better to rely on well-designed studies than on case series. It would be useful to have studies comparing vaptans with the measures considered to constitute first-line therapy. According to our criterion, vaptans would not be indicated in HN with serious neurological symptoms, due to their unpredictable response and insufficiently rapid effect.</p></span></span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Question seven. How to differentiate among SIADH, salt-wasting syndrome and adrenal insufficiency in hyponatremic patients? (<a class="elsevierStyleCrossRef" href="#sec0155">Table S2 of the supplementary material</a>)</span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Practical recommendations</span><p id="par0365" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">•</span><p id="par0370" class="elsevierStylePara elsevierViewall">It is important to establish a differential diagnosis between SIADH and salt-wasting syndrome (SWS), since opposite treatment strategies apply to these two conditions (free water restriction versus fluid therapy).</p></li><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">•</span><p id="par0375" class="elsevierStylePara elsevierViewall">Evaluate volemia and diuresis rate in order to distinguish between SIADH and SWS. However, both syndromes may form part of a mixed disorder, and their presentation depends on the intensity of each mechanism.</p></li><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel">•</span><p id="par0380" class="elsevierStylePara elsevierViewall">Avoid fluid loading and water restriction as a method for distinguishing between SIADH and SWS, since it may be counterproductive for the clinical course of the patient.</p></li><li class="elsevierStyleListItem" id="lsti0160"><span class="elsevierStyleLabel">•</span><p id="par0385" class="elsevierStylePara elsevierViewall">Determine basal cortisol for the diagnosis of adrenal insufficiency (AI). In the presence of inappropriately low values, the ACTH stimulation test is useful for distinguishing between primary and secondary presentations.</p></li><li class="elsevierStyleListItem" id="lsti0165"><span class="elsevierStyleLabel">•</span><p id="par0390" class="elsevierStylePara elsevierViewall">Administer 0.9% SS and intravenous glucose in the presence of hypoglycemia in patients with HN secondary to AI.</p></li><li class="elsevierStyleListItem" id="lsti0170"><span class="elsevierStyleLabel">•</span><p id="par0395" class="elsevierStylePara elsevierViewall">Administer replacement therapy with hydrocortisone (stress or maintenance dose) and fludrocortisone (following diagnostic confirmation), in addition to ensuring measures against hyperpotassemia in patients with HN secondary to AI.</p></li><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">•</span><p id="par0400" class="elsevierStylePara elsevierViewall">It is important to monitor sodium in blood and urine, Osm<span class="elsevierStyleInf">u</span> and the diuresis rate after starting treatment with glucocorticoids, since they can cause important aquaresis with the risk of over-correction.</p></li><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">•</span><p id="par0405" class="elsevierStylePara elsevierViewall">The presence of HN secondary to hypothyroidism is very infrequent and can only be regarded as a cause of HN if the condition is clearly serious.</p></li></ul></p><p id="par0410" class="elsevierStylePara elsevierViewall">In SWS of cerebral origin, HN is of a hypovolemic hypoosmolar nature resulting from neurological dysfunction secondary to brain damage. Its definition is currently not clear,<a class="elsevierStyleCrossRef" href="#bib0775"><span class="elsevierStyleSup">60</span></a> its diagnosis is exceptional,<a class="elsevierStyleCrossRef" href="#bib0815"><span class="elsevierStyleSup">68</span></a> and there are doubts about the underlying physiopathogenic mechanism involved.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">74</span></a> Natriuresis gives rise to a decrease in ECV that stimulates ADH.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">75</span></a> Proximal tubule alterations favor the excretion of uric acid, Na<span class="elsevierStyleSup">+</span> and phosphorus.<a class="elsevierStyleCrossRef" href="#bib0855"><span class="elsevierStyleSup">76</span></a> The condition is usually associated with hypouricemia, but this would not be a good marker for distinguishing between SIADH and SWS. Nevertheless, after correcting HN, the fractional excretion of uric acid may help to differentiate between the two disorders, since its value would remain elevated in the case of SWS (>12%). The treatment is based on fluid therapy to normalize ECV.<a class="elsevierStyleCrossRef" href="#bib0855"><span class="elsevierStyleSup">76</span></a></p><p id="par0415" class="elsevierStylePara elsevierViewall">Adrenal gland insufficiency occurs due to a deficit in adrenal hormone synthesis. In severe cases, the production of cortisol and aldosterone may be unable to meet the demands (stress), giving rise to HN. In some cases, neurological damage (traumatic brain injury or neurosurgery) gives rise to an alteration in ACTH release and secondarily to an alteration in cortisol output (secondary AI).<a class="elsevierStyleCrossRef" href="#bib0815"><span class="elsevierStyleSup">68</span></a></p></span></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Question eight. How should hyponatremia be treated in patients subjected to extrarenal filtration techniques?</span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Practical recommendations</span><p id="par0420" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">•</span><p id="par0425" class="elsevierStylePara elsevierViewall">We do not recommend extrarenal filtration techniques (EFTs) for the correction of HN.</p></li><li class="elsevierStyleListItem" id="lsti0190"><span class="elsevierStyleLabel">•</span><p id="par0430" class="elsevierStylePara elsevierViewall">Such techniques are a risk factor for the rapid correction of hyponatremia.</p></li><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">•</span><p id="par0435" class="elsevierStylePara elsevierViewall">We suggest avoiding citrate as anticoagulant if the patient presents severe HN.</p></li><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">•</span><p id="par0440" class="elsevierStylePara elsevierViewall">In order to avoid the rapid correction of natremia in patients with severe HN requiring EFT for any other reason, we consider the following to be useful:</p></li><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">∘</span><p id="par0445" class="elsevierStylePara elsevierViewall">Apply continuous extrarenal filtration techniques (CEFTs) instead of intermittent hemodialysis.</p></li><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">∘</span><p id="par0450" class="elsevierStylePara elsevierViewall">Add water to the commercial solutions used in CEFT to adjust to patient natremia. Use the lowest clearance dose.</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">∘</span><p id="par0455" class="elsevierStylePara elsevierViewall">Monitor natremia closely during CEFT.</p></li></ul></p><p id="par0460" class="elsevierStylePara elsevierViewall">Kidney disease is responsible for between 2 and 12% of all cases of HN. In patients requiring EFT and who suffer HN, although high uremia attenuates the effects of rapid [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> elevation, over-correction caused by the technique may occur (depending on the dose used and the sodium of the fluids). An alternative for avoiding this is to add sterile water in the dialysis bags in order to keep the sodium in the solutions between 6 and 8<span class="elsevierStyleHsp" style=""></span>mEq/l above the desired [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><a class="elsevierStyleCrossRefs" href="#bib0860"><span class="elsevierStyleSup">77–79</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>) and apply a low and sustained dose over time.<a class="elsevierStyleCrossRef" href="#bib0875"><span class="elsevierStyleSup">80</span></a></p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia><p id="par0465" class="elsevierStylePara elsevierViewall">The generalization of the use of citrate as anticoagulant in CEFT could represent a further source of problems in the management of HN, since hypernatremia is a complication that has been associated with its use. Furthermore, although they allow easy and safe citrate use, the automated systems now employed require a specific concentration of ions in the solutions, and these must not be manipulated. Therefore, although published evidence is lacking, the physiological bases and the mode of application of citrate make it impossible to guarantee a slow or controlled increase in natremia. We therefore recommend avoiding citrate as anticoagulant in the presence of severe HN, at least until further evidence becomes available.</p></span></span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Question nine. If over-correction occurs during the management of hyponatremia, how should it be treated?</span><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Practical recommendations</span><p id="par0470" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">•</span><p id="par0475" class="elsevierStylePara elsevierViewall">Reduce [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> in the event of over-correction in order to avoid cerebral ODS.</p></li><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">•</span><p id="par0480" class="elsevierStylePara elsevierViewall">Use 5% glucose solution to reduce natremia in the presence of over-correction.</p></li><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">•</span><p id="par0485" class="elsevierStylePara elsevierViewall">Use desmopressin in cases of excessive Na<span class="elsevierStyleSup">+</span><span class="elsevierStyleInf">p</span> elevation.</p></li><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">•</span><p id="par0490" class="elsevierStylePara elsevierViewall">The rate of correction must be controlled particularly in the presence of factors favoring over-correction: hypovolemia, hypoxemia, heavy beer intake, nausea, vomiting, pain, thiazides or serotonin reuptake inhibitors, adrenal insufficiency or CEFT, among others.</p></li></ul></p><p id="par0495" class="elsevierStylePara elsevierViewall">The monitoring of Osm<span class="elsevierStyleInf">u</span> and of urine volume may help predict the risk of over-correction.<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">81,82</span></a> If the intended limits are exceeded, and despite the scant available evidence, the guides recommend reducing [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> again using water via the enteral route, 5% glucose solution (3<span class="elsevierStyleHsp" style=""></span>ml/kg/h)<a class="elsevierStyleCrossRef" href="#bib0710"><span class="elsevierStyleSup">47</span></a> and/or desmopressin (2–4<span class="elsevierStyleHsp" style=""></span>μg i.v.)<a class="elsevierStyleCrossRef" href="#bib0890"><span class="elsevierStyleSup">83</span></a> in order to avoid ODS. Desmopressin induces the reabsorption of water by the collecting tubules, reducing natremia, and has been shown to be effective – though in the context of retrospective studies and case series.<a class="elsevierStyleCrossRefs" href="#bib0895"><span class="elsevierStyleSup">84,85</span></a></p></span></span></span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Algorithm for the diagnosis of hyponatremia</span><p id="par0500" class="elsevierStylePara elsevierViewall">The final objective of this panel of experts was to adopt a diagnostic algorithm of use in application to critical patients (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0505" class="elsevierStylePara elsevierViewall">In the presence of [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>135<span class="elsevierStyleHsp" style=""></span>mEq/l, we must confirm genuine HN (Osm<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>280<span class="elsevierStyleHsp" style=""></span>mOsm/kg). At this point, if the patient has severe symptoms, urgent management is required. Posteriorly, we should evaluate Osm<span class="elsevierStyleInf">u</span>, and if it is found to be <100<span class="elsevierStyleHsp" style=""></span>mOsm/kg, we must discard a high provision of hypotonic solutions or insufficient intake of sodium or proteins (potomania, heavy beer intake, use of ecstasy [MDMA] accompanied by water, hypoproteic diets). A situation of [K<span class="elsevierStyleSup">+</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> indicates that free water excretion is preserved. If Osm<span class="elsevierStyleInf">u</span> is >100<span class="elsevierStyleHsp" style=""></span>mOsm/kg or [K<span class="elsevierStyleSup">+</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>, free water excretion may be decreased and urinary [Na<span class="elsevierStyleSup">+</span>] should be assessed, since if it is found to be >30<span class="elsevierStyleHsp" style=""></span>mEq/l we need to discard renal disorders or diuretic intake, while in the case of <30<span class="elsevierStyleHsp" style=""></span>mEq/l we can assume that the kidneys compensate low ECV.</p><p id="par0510" class="elsevierStylePara elsevierViewall">We must assess volemia, since diuretics, SWS or adrenal insufficiency are characterized by reduced volemia and SIADH, hypothyroidism or glucocorticoid deficit with normovolemia. Total body water can provide an orientation, for if it is found to be low, we must discard extrarenal water and sodium losses, while a high water total body water content (edemas) requires us to discard congestive heart failure, nephrotic syndrome or cirrhosis.</p></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Conclusions</span><p id="par0515" class="elsevierStylePara elsevierViewall">Hyponatremia is common in the ICU, and in this setting, the signs and symptoms it causes are often masked by the disease condition for which the patient was admitted to the Unit, or by the characteristics inherent to patients of this kind (e.g., sedation). This makes it difficult to critically assess the impact of HN. On the other hand, the underlying etiopathogenic mechanisms in these patients tend to be complex, since in some cases the background disease itself is associated to the origin of HN, while in other cases it is integrated within the physiopathological response to aggression – thereby complicating correction of the problem.</p><p id="par0520" class="elsevierStylePara elsevierViewall">Natremia depends on the balance between sodium and water input and losses, and in our patients this balance is often conditioned by our treatment decisions.</p><p id="par0525" class="elsevierStylePara elsevierViewall">The threshold for defining hyponatremia depends on the clinical characteristics, and these in turn influence the need for correction and the speed or rate at which it can be applied.</p><p id="par0530" class="elsevierStylePara elsevierViewall">Hyponatremia produces acute neurological dysfunction due to brain edema, but rapid correction of HN can give rise to neuronal damage (ODS). Management therefore must be adapted to the severity of the symptoms, the duration of the disorder and its cause, with individualized evaluation of the risk of over-correction.</p><p id="par0535" class="elsevierStylePara elsevierViewall">Aspects apparently little related to HN and which form an important part of our clinical practice, such as the use of CEFT, may unexpectedly influence the evolution of HN or its correction.</p><p id="par0540" class="elsevierStylePara elsevierViewall">Algorithms reduce the variability of clinical practice, but those available for the management of HN are not specifically targeted to the critical patient. This makes it desirable to have algorithms such as that proposed herein – though we must underscore that any algorithm should be complemented by the knowledge of the experienced intensivist.</p><p id="par0545" class="elsevierStylePara elsevierViewall">The main limitation of this document is that the literature search was not systematic and is therefore not reproducible, since from the initial search we selected and added publications according to the individual criteria of the different members of the group of experts. On the other hand, the consensus-based recommendations of this document are largely fundamented on the experience and opinions of the authors, with no high-quality scientific evidence due to the scarcity of clinical trials and controlled studies that would have allowed evidence-based recommendations to be made in reference to most of the therapeutic issues raised. Therefore, the practical recommendations of this document lack a protocol with which to grade the supporting evidence; nevertheless, we feel that the recommendations can be useful in routine clinical practice, since they have been developed and agreed upon by physicians with great experience in dealing with patients with hyponatremia admitted to the ICU.</p><p id="par0550" class="elsevierStylePara elsevierViewall">On the other hand, while the meetings held to develop the project were auspiced by <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>, in no way did this company influence our contributions and recommendations.</p><p id="par0555" class="elsevierStylePara elsevierViewall">The document and resulting algorithm of this project seek to clarify and reduce variability in the management of these patients, and in the not too distant future we hope it will facilitate evaluation of the specific impact of hyponatremia in our patients. It is our wish for this document to promote the development of HN registries in Spanish ICUs, with a view to improving knowledge of the disorder among the critically ill.</p></span><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">Financial support</span><p id="par0560" class="elsevierStylePara elsevierViewall">Development of this document received financial support from <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>, which covered the expenses referred to transport of the members of the panel and the cost derived from the meetings. All the panel members declare having received payment for their participation, though not in relation to development of the manuscript – the editorial contents of which reside exclusively in its authors.</p></span><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">Conflicts of interest</span><p id="par0565" class="elsevierStylePara elsevierViewall">The panel members declare the following conflicts of interest:</p><p id="par0570" class="elsevierStylePara elsevierViewall">M.J. Broch-Porcar has received payment for conferences from <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span> and Fresenius, and for participating in symposia organized by <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p><p id="par0575" class="elsevierStylePara elsevierViewall">J.M. Domínguez-Roldán has received payment for conferences from Integra Neurosciences, <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span> and Masimo Corporation, and for participating in symposia organized by <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p><p id="par0580" class="elsevierStylePara elsevierViewall">B. Rodríguez-Cubillo declares having no conflicts of interest.</p><p id="par0585" class="elsevierStylePara elsevierViewall">L. Álvarez-Rocha has received lecture payments from Pfizer and <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p><p id="par0590" class="elsevierStylePara elsevierViewall">M.A. Ballesteros-Sanz has received lecture payments from <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span> and Astellas.</p><p id="par0595" class="elsevierStylePara elsevierViewall">M. Cervera-Montes has received conference and lecture payments from Nestle, Abbot Nutrition, Fresenius Kabi, Pfizer, Philips and Covidien.</p><p id="par0600" class="elsevierStylePara elsevierViewall">M. Chico-Fernández has received lecture payments from MSD, Octapharma, Behring and <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>, and has participated in the NOSTRA trial of GmpVasopharma.</p><p id="par0605" class="elsevierStylePara elsevierViewall">J.H. de Gea-García has received lecture payments from <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span> and Astra Zeneca.</p><p id="par0610" class="elsevierStylePara elsevierViewall">P. Enríquez-Giraudo declares having no conflicts of interest.</p><p id="par0615" class="elsevierStylePara elsevierViewall">A. García de Lorenzo y Mateos declares having no conflicts of interest.</p><p id="par0620" class="elsevierStylePara elsevierViewall">R. Gómez-López has received payment for conferences from Astra Zeneca and Pfizer, and for scientific counseling from Cardiolife, Maquet, AstraZeneca and <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p><p id="par0625" class="elsevierStylePara elsevierViewall">R. Guerrero-Pavón declares having no conflicts of interest.</p><p id="par0630" class="elsevierStylePara elsevierViewall">F. López-Sánchez declares having no conflicts of interest.</p><p id="par0635" class="elsevierStylePara elsevierViewall">J.A. Llompart-Pou has received payment for conferences from <span class="elsevierStyleItalic">Otsuka pharmaceutical</span>.</p><p id="par0640" class="elsevierStylePara elsevierViewall">S. Lubillo-Montenegro has received payment for conferences from Integra Neurosciences up until June 2014.</p><p id="par0645" class="elsevierStylePara elsevierViewall">Z. Molina-Collado declares having no conflicts of interest.</p><p id="par0650" class="elsevierStylePara elsevierViewall">P. Ramírez-Galleymore has received payment for conferences from Pfizer, MSD, <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span> and Novartis and for participating in symposia organized by <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p><p id="par0655" class="elsevierStylePara elsevierViewall">M. Riveiro-Vilaboa declares having no conflicts of interest.</p><p id="par0660" class="elsevierStylePara elsevierViewall">A. Sánchez-Corral declares having no conflicts of interest.</p><p id="par0665" class="elsevierStylePara elsevierViewall">M.E. Herrera-Gutiérrez has received payment for conferences from Baxter, Fresenius and <span class="elsevierStyleItalic">Otsuka Pharmaceutical</span>.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:17 [ 0 => array:3 [ "identificador" => "xres1198450" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1116951" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1198451" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1116950" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Methodology used to produce the document" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Definition of hyponatremia" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Incidence and prognosis of hyponatremia in the critical patient" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Physiopathology of hyponatremia" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Neurological repercussions of hyponatremia" ] 10 => array:3 [ "identificador" => "sec0035" "titulo" => "Practical concepts referred to the critical patient with hyponatremia" "secciones" => array:9 [ 0 => array:3 [ "identificador" => "sec0040" "titulo" => "Question one. How is hyponatremia classified?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Practical recommendations" ] ] ] 1 => array:3 [ "identificador" => "sec0050" "titulo" => "Question two. What is the importance of volemia evaluation in the hyponatremic critical patient?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0055" "titulo" => "Practical recommendations" ] ] ] 2 => array:3 [ "identificador" => "sec0060" "titulo" => "Question three. What are the natremia correction and monitoring objectives in hyponatremic patients?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Practical recommendations" ] ] ] 3 => array:3 [ "identificador" => "sec0070" "titulo" => "Question four. What is the most appropriate treatment for hyponatremic patients according to the type of natremia involved?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0075" "titulo" => "Practical recommendations" ] ] ] 4 => array:3 [ "identificador" => "sec0080" "titulo" => "Question five. Is it important to study the causes of secondary syndrome of inappropriate antidiuretic hormone secretion in the critical patient?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0085" "titulo" => "Practical recommendations" ] ] ] 5 => array:3 [ "identificador" => "sec0090" "titulo" => "Question six. What is the appropriate treatment for correcting hyponatremia in patients with SIADH?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0095" "titulo" => "Practical recommendations" ] ] ] 6 => array:3 [ "identificador" => "sec0100" "titulo" => "Question seven. How to differentiate among SIADH, salt-wasting syndrome and adrenal insufficiency in hyponatremic patients? (Table S2 of the supplementary material)" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0105" "titulo" => "Practical recommendations" ] ] ] 7 => array:3 [ "identificador" => "sec0110" "titulo" => "Question eight. How should hyponatremia be treated in patients subjected to extrarenal filtration techniques?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0115" "titulo" => "Practical recommendations" ] ] ] 8 => array:3 [ "identificador" => "sec0120" "titulo" => "Question nine. If over-correction occurs during the management of hyponatremia, how should it be treated?" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0125" "titulo" => "Practical recommendations" ] ] ] ] ] 11 => array:2 [ "identificador" => "sec0130" "titulo" => "Algorithm for the diagnosis of hyponatremia" ] 12 => array:2 [ "identificador" => "sec0135" "titulo" => "Conclusions" ] 13 => array:2 [ "identificador" => "sec0140" "titulo" => "Financial support" ] 14 => array:2 [ "identificador" => "sec0145" "titulo" => "Conflicts of interest" ] 15 => array:2 [ "identificador" => "xack409902" "titulo" => "Acknowledgment" ] 16 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-04-21" "fechaAceptado" => "2018-12-09" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1116951" "palabras" => array:9 [ 0 => "Hyponatremia" 1 => "Critical care patients" 2 => "Differential diagnosis" 3 => "Etiology" 4 => "Prognosis" 5 => "Algorithm" 6 => "Classification" 7 => "Treatment" 8 => "Vaptans" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1116950" "palabras" => array:9 [ 0 => "Hiponatremia" 1 => "Pacientes críticos" 2 => "Diagnóstico diferencial" 3 => "Etiología" 4 => "Pronóstico" 5 => "Algoritmo" 6 => "Clasificación" 7 => "Tratamiento" 8 => "Vaptanes" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Hyponatremia is the most prevalent electrolyte disorder in Intensive Care Units. It is associated with an increase in morbidity, mortality and hospital stay. The majority of the published studies are observational, retrospective and do not include critical patients; hence it is difficult to draw definitive conclusions.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Moreover, the lack of clinical evidence has led to important dissimilarities in the recommendations coming from different scientific societies.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Finally, etiopathogenic mechanisms leading to hyponatremia in the critical care patient are complex and often combined, and an intensive analysis is clearly needed. A study was therefore made to review all clinical aspects about hyponatremia management in the critical care setting. The aim was to develop a Spanish nationwide algorithm to standardize hyponatremia diagnosis and treatment in the critical care patient.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">La hiponatremia es el trastorno electrolítico más prevalente en las Unidades de Cuidados Intensivos. Se asocia a un aumento de la morbilidad, mortalidad y estancia hospitalaria. La mayoría de los estudios publicados hasta el momento son observacionales, retrospectivos y no incluyen pacientes críticos, lo que dificulta la extracción de conclusiones sólidas. Además, debido a la escasa evidencia científica de calidad, incluso las recomendaciones realizadas por distintas sociedades científicas recientemente publicadas difieren en aspectos importantes como son el diagnóstico o el tratamiento de la hiponatremia.</p><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Los mecanismos etiopatogénicos en los pacientes críticos suelen ser complejos. Sin embargo, hay que profundizar en ellos para llegar al diagnóstico más probable y a la pauta de tratamiento más adecuada. Todo ello, ha motivado la realización de esta revisión práctica sobre aspectos útiles en el abordaje de la hiponatremia en las Unidades de Cuidados intensivos, con el objetivo de homogeneizar el manejo de esta entidad y disponer de un algoritmo diagnóstico a nivel nacional.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Please cite this article as: Broch Porcar MJ, Rodríguez Cubillo B, Domínguez-Roldán JM, Álvarez Rocha L, Ballesteros Sanz MÁ, Cervera Montes M, et al. Documento práctico del manejo de la hiponatremia en pacientes críticos. Med Intensiva. 2019;43:302–316.</p>" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0680" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article:<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary data" "identificador" => "sec0155" ] ] ] ] "multimedia" => array:8 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1861 "Ancho" => 3390 "Tamanyo" => 333731 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Hyponatremia diagnostic algorithm.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">ADH: antidiuretic hormone; CHF: congestive heart failure; [K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span>: sum of urinary concentration of sodium and potassium; [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span>: urinary concentration of sodium; Osm<span class="elsevierStyleInf">p</span>: plasma osmolality; Osm<span class="elsevierStyleInf">u</span>: urine osmolality; SIADH: syndrome of inappropriate ADH secretion; ECV: effective circulating volume.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Total body water \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Volemia (ECV) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ADH secretion \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ADH effect \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">[K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span> (free water excretion) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Osm<span class="elsevierStyleInf">u</span> (mOsm/kg) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Examples \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypervolemic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High, non-osmotic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water retention<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>sodium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>(decreased) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High(>Osm<span class="elsevierStyleInf">p</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Variable \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cirrhosis, CHF, nephrotic syndrome \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Correction ECV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normovolemic</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High, non-physiological \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No pathological water excretion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>(decreased) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High(>100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SIADH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Treatment SIADH \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No sufficient water excretion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>(elevated, insufficient) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Low(<100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Low \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Polydipsia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water restriction \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypovolemic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Low \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High, osmotic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water retention<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>sodium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[K<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">u</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>(decreased) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High(>100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Low \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dehydration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hydration \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046770.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Interpretation of laboratory test values in hypotonic hyponatremia (Osm<span class="elsevierStyleInf">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>280<span class="elsevierStyleHsp" style=""></span>mOsm/kg).</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Source: Vervalis et al.<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">1</span></a> and Spasovski et al.<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">2</span></a></p>" "tablatextoimagen" => array:4 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">According to plasma concentration of sodium</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Natremia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> (mEq/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Analytical techniques \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mild \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">134–130 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Recommended for measurement of [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span>:•Direct measurement•Always the same technique•Selective ion flux electrode</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">129–125 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Severe \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><125 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046765.png" ] ] 1 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">According to tonicity</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tonicity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Osm<span class="elsevierStyleInf">p</span> (mOsm/kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Degree of osmolality \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Example \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">It is advisable to measure Osm<span class="elsevierStyleInf">p</span> rather than calculate it</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypotonic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><280 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypoosmolar \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SIADH \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Isotonic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">280–290 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Isosmolar \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hyperlipidemia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hyperproteinemia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypertonic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>290 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hyperosmolar \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hyperglycemia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mannitol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046766.png" ] ] 2 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">According to symptoms</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Degree of severity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Symptoms \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mild \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No altered consciousness: headache, asthenia, weakness, attention deficit, memory or gait alterations, slowed mental reaction \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Altered consciousness: nausea, vomiting, disorientation, delirium, confusion, drowsiness, weaning difficulties \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Severe \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Neurological dysfunction: stupor, seizures, coma, brain herniation, death, non-cardiogenic lung edema \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046763.png" ] ] 3 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">According to speed of onset</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Onset time \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Associated symptoms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">If not known, it is advisable to assume hyponatremia as chronic, since treatment will be less aggressive, in order to avoid risk of osmotic demyelinating syndrome (ODS)</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acute \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><48<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">More frequent neurological symptoms (greater brain edema) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Chronic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>48<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Attention deficit, altered balance, osteoporosis and bone fractures, falls \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046764.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Classification of hyponatremia according to different criteria.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">GEDI: Global End Diastolic Volume Index; ITBVI: Intrathoracic Blood Volume Index; mmHg: millimeters of mercury; PCP: pulmonary capillary pressure; CVP: central venous pressure; Δresp: respiratory variation; SR: sinus rhythm; TD: left ventricular filling flow deceleration time; AW: acoustic window; IVCd: diameter of the inferior vena cava; MV: mechanical ventilation; CMV: controlled mechanical ventilation; VPP: variation of pulse pressure; SV: systolic (stroke) volume; ΔVPV LVOT: variation of peak flow velocity of the left ventricular outflow tract; SVV: stroke volume variation.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Methods \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Hypovolemia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Normovolemia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Hypervolemia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Advantages \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Limitations \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="7" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Non-instrumental</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Clinical history</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Renal and extrarenal losses.Negative balance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Neutral balance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cirrhosis, CHF, nephrotic syndrome, fluid therapy. Positive balance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Always indicated \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Not objective \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Physical examination</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Diminished ocular tone, mucocutaneous dryness, weight below basal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No data of hypo- or hypervolemia.No weight changes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Edemas, ascites, pleural effusion, weight gain \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Always indicated \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Not objective \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="7" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Static instrumental</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Bioimpedance</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Low body water percentage \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water, fat and lean mass balanced \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High body water percentage \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Noninvasive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No experience in ICUAltered if hyponatremia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Ultrasound</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IVCd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><12<span class="elsevierStyleHsp" style=""></span>mm (Δresp<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>50%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>An intermediate value is not evaluable \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>20<span class="elsevierStyleHsp" style=""></span>mm (Δresp<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>50%)A high value is exceptional in hypovolemia, but does not imply hypervolemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NoninvasiveBasic ultrasound \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Learning curve.Interfered by MV and AW \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">E/e’ ratio \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><8Low values suggested non-elevated pressures, though a low value does not imply hypovolemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>15High values are associated to high ventricular filling pressures, more frequent in hypervolemic patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Noninvasive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Also, only if LVEF<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>40%.Advanced ultrasound \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">E/A ratio \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><1 (E<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>cm/s)Low values suggested non-elevated pressures, though a low value does not imply hypovolemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>2 (TD<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>150<span class="elsevierStyleHsp" style=""></span>ms)High values are associated to high ventricular filling pressures, more frequent in hypervolemic patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Noninvasive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Also, only if LVEF<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>40%.Advanced ultrasound \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>CVP (mmHg)</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">General use \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Invasive.Useful only in extreme values \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>PCP (mmHg)</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Gold standard \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>ITBVI</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><850<span class="elsevierStyleHsp" style=""></span>ml/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>1000<span class="elsevierStyleHsp" style=""></span>ml/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Precise static variable \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>GEDI</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><600<span class="elsevierStyleHsp" style=""></span>ml/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>800<span class="elsevierStyleHsp" style=""></span>ml/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Most precise static variable \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="7" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Dynamic instrumental</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>SVV</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>10% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Predict response to volume.Scantly invasive</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Do not estimate volemia.Limited to CMV in SR</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>VPP</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>13% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>ΔVPV LVOT</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>12% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Also, advanced ultrasound \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Raising of legs</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Increase of SV<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>10% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Also validates in arrhythmias and spontaneous ventilation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Do not estimate volemia \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046769.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">SV can be measured by ultrasound, esophageal doppler, pulse wave analysis systems or thermodilution.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">No data available in such circumstances.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Methods for estimating hydration status in the critical patient.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">h: h; mmol/l: millimoles per liter; K<span class="elsevierStyleSup">+</span>: potassium; Na<span class="elsevierStyleSup">+</span>: sodium; p: plasmatic; ODS: osmotic demyelinating syndrome.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Management of hyponatremia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Objective \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Ideal Na<span class="elsevierStyleSup">+</span> increase \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Maximum Na<span class="elsevierStyleSup">+</span> increase \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Recommended rate of increase [Na<span class="elsevierStyleSup">+</span>]<span class="elsevierStyleInf">p</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Monitoring \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acute, severe \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Control of neurological symptoms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>mmol/l in 6<span class="elsevierStyleHsp" style=""></span>h8<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h(general)12<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h(neurocritical)6<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h(risk ODS) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>h: 0.5–2<span class="elsevierStyleHsp" style=""></span>mmol/l6<span class="elsevierStyleHsp" style=""></span>h: 2–5<span class="elsevierStyleHsp" style=""></span>mmol/l24<span class="elsevierStyleHsp" style=""></span>h: 6–8<span class="elsevierStyleHsp" style=""></span>mmol/l48<span class="elsevierStyleHsp" style=""></span>h: 12–14<span class="elsevierStyleHsp" style=""></span>mmol/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[Na<span class="elsevierStyleSup">+</span>], [K<span class="elsevierStyleSup">+</span>] plasma and urine every 2<span class="elsevierStyleHsp" style=""></span>h in the first 6<span class="elsevierStyleHsp" style=""></span>h.[Na<span class="elsevierStyleSup">+</span>], [K<span class="elsevierStyleSup">+</span>] plasma and urine every 4<span class="elsevierStyleHsp" style=""></span>h until first 24<span class="elsevierStyleHsp" style=""></span>hHourly diuresis \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acute, not severe \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Correction of [Na<span class="elsevierStyleSup">+</span>] to >120<span class="elsevierStyleHsp" style=""></span>mmol/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6–8<span class="elsevierStyleHsp" style=""></span>mmol/l every 24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24<span class="elsevierStyleHsp" style=""></span>h: 6–8<span class="elsevierStyleHsp" style=""></span>mmol/l48<span class="elsevierStyleHsp" style=""></span>h: 12–14<span class="elsevierStyleHsp" style=""></span>mmol/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[Na<span class="elsevierStyleSup">+</span>], [K<span class="elsevierStyleSup">+</span>] plasma and urine every 8<span class="elsevierStyleHsp" style=""></span>h.Diuresis every 8<span class="elsevierStyleHsp" style=""></span>h. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Chronic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Correction of [Na<span class="elsevierStyleSup">+</span>] to >120<span class="elsevierStyleHsp" style=""></span>mmol/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4–6<span class="elsevierStyleHsp" style=""></span>mmol/l every 24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>mmol/l in 24<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24<span class="elsevierStyleHsp" style=""></span>h: 4–6<span class="elsevierStyleHsp" style=""></span>mmol/l48<span class="elsevierStyleHsp" style=""></span>h: 12<span class="elsevierStyleHsp" style=""></span>mmol/l \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[Na<span class="elsevierStyleSup">+</span>], [K<span class="elsevierStyleSup">+</span>] plasma and urine every 8<span class="elsevierStyleHsp" style=""></span>h.Diuresis every 8<span class="elsevierStyleHsp" style=""></span>h. \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046762.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Treatment of hyponatremia.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at5" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">CHF: congestive heart failure; NaCl: sodium chloride; Osm u: urinary osmolality; SIADH: syndrome of inappropriate ADH secretion; SWS: salt-wasting syndrome; 3% HSS: 3% hypertonic saline solution.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">First line \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Second line \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Not recommended \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CHF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Specific treatmentWater restriction3% HSS (on point basis, if water overload allows)Furosemide if high Osm u<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">13</span></a></td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " rowspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vaptans in case of neurological symptoms or refractory to treatment or impossibility of first line treatment<a class="elsevierStyleCrossRefs" href="#bib0790"><span class="elsevierStyleSup">63,64,86–88</span></a> (not approved [off-label] in Summary of Product Characteristics in Spain)</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3% HSS in case of important water overload due to risk of worsening CHF \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cirrhosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3% HSS in case of important water overload due to risk of worsening edema-ascites decompensation \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cranial hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3% HSS<a class="elsevierStyleCrossRef" href="#bib0920"><span class="elsevierStyleSup">89</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hydrocortisone/fludrocortisone \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water restriction due to difficulty in intubated patient and risk of SWS<a class="elsevierStyleCrossRef" href="#bib0925"><span class="elsevierStyleSup">90</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Postsurgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Control of factors that trigger SIADH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Fluid therapy adjusted to input and losses balance \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Fluid therapy excessive or with hypotonic fluids.Vaptans if suspected SWS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SIADH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Water restrictionCapsules of NaCl3% HSSFurosemide if high Osm u<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">75</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vaptans is refractory or impossibility of first line treatment (approved in Spain)<a class="elsevierStyleCrossRefs" href="#bib0760"><span class="elsevierStyleSup">57,61,91</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lithium,<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">56</span></a> demeclocycline,<a class="elsevierStyleCrossRef" href="#bib0935"><span class="elsevierStyleSup">92</span></a> urea<a class="elsevierStyleCrossRef" href="#bib0940"><span class="elsevierStyleSup">93</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypovolemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.9% saline solution<a class="elsevierStyleCrossRefs" href="#bib0945"><span class="elsevierStyleSup">94,95</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Packed red cells if bleeding \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Fluid therapy with hypotonic fluids, vaptans<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">58</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046768.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Treatment of hyponatremia according to associated disease.</p>" ] ] 6 => array:8 [ "identificador" => "tbl0030" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at6" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">mEq/l: milliequivalents per liter; ml: ml; Na<span class="elsevierStyleSup">+</span>: sodium.</p><p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Source: Yessayan et al.<a class="elsevierStyleCrossRef" href="#bib0870"><span class="elsevierStyleSup">79</span></a></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Water to add (ml) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">[Na<span class="elsevierStyleSup">+</span>] final objective (mEq/l) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Bicarbonate final objective (mEq/l) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">150 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">136 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">250 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">133 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">33 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">500 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">127 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">32 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">750 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">122 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1000 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">117 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1250 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">112 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2046767.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Water dose to be added to 5-liter bags of CEFT exchanger bath.</p>" ] ] 7 => array:5 [ "identificador" => "upi0005" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "Ecomponente" => array:2 [ "fichero" => "mmc1.pdf" "ficheroTamanyo" => 150754 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:95 [ 0 => array:3 [ "identificador" => "bib0480" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2013.07.006" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2013" "volumen" => "126" "numero" => "Suppl. 1" "paginaInicial" => "S1" "paginaFinal" => "S42" "link" => array:1 [ …1] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0485" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical practice guideline on diagnosis and treatment of hyponatraemia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00134-014-3210-2" "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2014" "volumen" => "40" "paginaInicial" => "320" "paginaFinal" => "331" "link" => array:1 [ …1] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0490" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of hyponatremia in patients with acute neurological injury" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Neurocrit Care" "fecha" => "2017" "volumen" => "27" "paginaInicial" => "242" "paginaFinal" => "248" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0495" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of hyponatremia: compilation of the guidelines" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2016101139" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2017" "volumen" => "28" "paginaInicial" => "1340" "paginaFinal" => "1349" "link" => array:1 [ …1] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0500" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alteraciones del sodio y el agua" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3265/Nefrología.2010.pub1.ed80.chapter 2796" "Revista" => array:3 [ "tituloSerie" => "Nefrología al día" "fecha" => "2012" "volumen" => "7" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0505" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12028-009-9238-4" "Revista" => array:6 [ "tituloSerie" => "Neurocrit Care" "fecha" => "2009" "volumen" => "11" "paginaInicial" => "228" "paginaFinal" => "234" "link" => array:1 [ …1] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0510" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia in cirrhosis: pathophysiology and management" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v21.i11.3197" "Revista" => array:6 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2015" "volumen" => "21" "paginaInicial" => "3197" "paginaFinal" => "3205" "link" => array:1 [ …1] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0515" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur J Heart Fail" "fecha" => "2006" "volumen" => "8" "paginaInicial" => "697" "paginaFinal" => "705" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0520" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc11805" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2013" "volumen" => "17" "paginaInicial" => "206" "link" => array:1 [ …1] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0525" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semnephrol.2009.03.004" "Revista" => array:6 [ "tituloSerie" => "Semin Nephrol" "fecha" => "2009" "volumen" => "29" "paginaInicial" => "227" "paginaFinal" => "238" "link" => array:1 [ …1] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0530" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality and serum sodium: do patients die from or with hyponatremia?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.10101110" "Revista" => array:6 [ "tituloSerie" => "Clin J Am Soc Nephrol" "fecha" => "2011" "volumen" => "6" "paginaInicial" => "960" "paginaFinal" => "965" "link" => array:1 [ …1] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0535" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patterns of treatment and correction of hyponatremia in intensive care unit patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcrc.2015.06.016" "Revista" => array:6 [ "tituloSerie" => "J Crit Care" "fecha" => "2015" "volumen" => "30" "paginaInicial" => "1072" "paginaFinal" => "1079" "link" => array:1 [ …1] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0540" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Disorders of plasma sodium – causes, consequences, and correction" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra1404489" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2015" "volumen" => "372" "paginaInicial" => "55" "paginaFinal" => "65" "link" => array:1 [ …1] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0545" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Central regulation of body-fluid homeostasis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.tins.2013.08.004" "Revista" => array:6 [ "tituloSerie" => "Trends Neurosci" "fecha" => "2013" "volumen" => "36" "paginaInicial" => "661" "paginaFinal" => "673" "link" => array:1 [ …1] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0550" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mycophenolate mofetil: an update" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Drugs Today (Barc)" "fecha" => "2009" "volumen" => "45" "paginaInicial" => "521" "paginaFinal" => "532" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0555" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms counteracting swelling in brain cells during hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Med Res" "fecha" => "2002" "volumen" => "33" "paginaInicial" => "237" "paginaFinal" => "244" "link" => array:1 [ …1] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0560" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Water entry into astrocytes during brain edema formation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/glia.20664" "Revista" => array:6 [ "tituloSerie" => "Glia" "fecha" => "2008" "volumen" => "56" "paginaInicial" => "895" "paginaFinal" => "902" "link" => array:1 [ …1] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0565" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Energy-dependent volume regulation in primary cultured cerebral astrocytes" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jcp.1041280211" "Revista" => array:6 [ "tituloSerie" => "J Cell Physiol" "fecha" => "1986" "volumen" => "128" "paginaInicial" => "209" "paginaFinal" => "215" "link" => array:1 [ …1] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0570" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1152/ajprenal.00502.2007" "Revista" => array:6 [ "tituloSerie" => "Am J Physiol Renal Physiol" "fecha" => "2008" "volumen" => "295" "paginaInicial" => "F619" "paginaFinal" => "F624" "link" => array:1 [ …1] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0575" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adaptive responses to sustained volume expansion in hyponatraemic rats" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Endocrinol" "fecha" => "1989" "volumen" => "122" "paginaInicial" => "421" "paginaFinal" => "431" "link" => array:1 [ …1] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0580" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Brain Res" "fecha" => "1991" "volumen" => "567" "paginaInicial" => "274" "paginaFinal" => "282" "link" => array:1 [ …1] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0585" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurochem Res" "fecha" => "2004" "volumen" => "29" "paginaInicial" => "73" "paginaFinal" => "81" "link" => array:1 [ …1] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0590" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cellular volume homeostasis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1152/advan.00034.2004" "Revista" => array:7 [ "tituloSerie" => "Adv Physiol Educ" "fecha" => "2004" "volumen" => "28" "numero" => "1–4" "paginaInicial" => "155" "paginaFinal" => "159" "link" => array:1 [ …1] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0595" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postoperative hyponatremic encephalopathy in menstruant women" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1992" "volumen" => "117" "paginaInicial" => "891" "paginaFinal" => "897" "link" => array:1 [ …1] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0600" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of hyponatremia on the brain" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jcm3041163" "Revista" => array:6 [ "tituloSerie" => "J Clin Med" "fecha" => "2014" "volumen" => "3" "paginaInicial" => "1163" "paginaFinal" => "1177" "link" => array:1 [ …1] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0605" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Central pontine myelinolysis: historical and mechanistic considerations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11011-010-9175-0" "Revista" => array:6 [ "tituloSerie" => "Metab Brain Dis" "fecha" => "2010" "volumen" => "25" "paginaInicial" => "97" "paginaFinal" => "106" "link" => array:1 [ …1] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0610" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia in the intensive care unit: how to avoid a Zugzwang situation?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Ann Intensive Care" "fecha" => "2015" "volumen" => "5" "paginaInicial" => "39" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0615" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11910-015-0536-2" "Revista" => array:5 [ "tituloSerie" => "Curr Neurol Neurosci Rep" "fecha" => "2015" "volumen" => "15" "paginaInicial" => "18" "link" => array:1 [ …1] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0620" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The pathophysiology and treatment of hyponatraemic encephalopathy: an update" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nephrol Dial" "fecha" => "2003" "volumen" => "18" "paginaInicial" => "2486" "paginaFinal" => "2491" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0625" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality after hospitalization with mild, moderate, and severe hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2009.01.027" "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "2009" "volumen" => "122" "paginaInicial" => "857" "paginaFinal" => "865" "link" => array:1 [ …1] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0630" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200005253422107" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "342" "paginaInicial" => "1581" "paginaFinal" => "1589" "link" => array:1 [ …1] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0635" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/qjmed/hci081" "Revista" => array:6 [ "tituloSerie" => "QJM" "fecha" => "2005" "volumen" => "98" "paginaInicial" => "529" "paginaFinal" => "540" "link" => array:1 [ …1] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0640" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198606123142401" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1986" "volumen" => "314" "paginaInicial" => "1529" "paginaFinal" => "1535" "link" => array:1 [ …1] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0645" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain volume regulation in response to hypo-osmolality and its correction" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2006.05.003" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2006" "volumen" => "119" "numero" => "Suppl. 1" "paginaInicial" => "S12" "paginaFinal" => "S16" "link" => array:1 [ …1] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0650" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pseudohyponatremia revisited: a modern-day pitfall" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/2010-0018-RS.1" "Revista" => array:6 [ "tituloSerie" => "Arch Pathol Lab Med" "fecha" => "2011" "volumen" => "135" "paginaInicial" => "516" "paginaFinal" => "519" "link" => array:1 [ …1] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0655" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia: a review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0885066614566794" "Revista" => array:6 [ "tituloSerie" => "J Intensive Care Med" "fecha" => "2016" "volumen" => "31" "paginaInicial" => "223" "paginaFinal" => "236" "link" => array:1 [ …1] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0660" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc11937" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2013" "volumen" => "17" "paginaInicial" => "R12" "link" => array:1 [ …1] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0665" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol (Oxf)" "fecha" => "2006" "volumen" => "64" "paginaInicial" => "250" "paginaFinal" => "254" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0670" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical review: disorders of water homeostasis in neurosurgical patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2011-3201" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2012" "volumen" => "97" "paginaInicial" => "1423" "paginaFinal" => "1433" "link" => array:1 [ …1] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0675" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia revisited: translating physiology to practice" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000119709" "Revista" => array:6 [ "tituloSerie" => "Nephron Physiol" "fecha" => "2008" "volumen" => "108" "paginaInicial" => "p46" "paginaFinal" => "p59" "link" => array:1 [ …1] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0680" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical assessment of extracellular fluid volume in hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Med" "fecha" => "1987" "volumen" => "83" "paginaInicial" => "905" "paginaFinal" => "908" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0685" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2014.06.001" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2014" "volumen" => "64" "paginaInicial" => "681" "paginaFinal" => "684" "link" => array:1 [ …1] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0690" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The rational clinical examination: is this patient hypovolemic?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1999" "volumen" => "281" "paginaInicial" => "1022" "paginaFinal" => "1029" "link" => array:1 [ …1] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0695" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consequences of inadequate management of hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Nephrol" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "240" "paginaFinal" => "249" ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0700" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CT-pro-AVP as a tool for assessment of intravascular volume depletion in severe hyponatremia" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clinbiochem.2015.03.013" "Revista" => array:7 [ "tituloSerie" => "Clin Biochem" "fecha" => "2015" "volumen" => "48" "numero" => "10–11" "paginaInicial" => "640" "paginaFinal" => "645" "link" => array:1 [ …1] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0705" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Water and sodium retention in edematous disorders: role of vasopressin and aldosterone" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2006.05.007" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2006" …5 ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0710" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treating profound hyponatremia: a strategy for controlled correction" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0715" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain dehydration and neurologic deterioration after rapid correction of hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0720" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of severe hyponatremia: rapid or slow correction?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0725" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.ki.5000187" "Revista" => array:6 [ …6] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0730" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid correction of chronic hyponatremia secondary to psychogenic polydipsia: hypoxic injury or extrapontine myelinolysis?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4088/PCC.15l01872" "Revista" => array:3 [ …3] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0735" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osmotic demyelination syndrome following slow correction of hyponatremia: possible role of hypokalemia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0972-5229.118433" "Revista" => array:6 [ …6] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0740" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: a prospective observational trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0972-5229.76079" "Revista" => array:6 [ …6] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0745" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypertonic saline for hyponatremia: risk of inadvertent overcorrection" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0750" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Caution of overdependence on formulas while treating hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ …3] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0755" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0760" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vasopressin antagonists" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0765" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa065181" "Revista" => array:6 [ …6] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0770" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ficha técnica de Samsca (Tolvaptan) en España (<a href="https://ec.europa.eu/health/documents/communityregister/2009/2009080362188/anx_6%202188_es.pdf">https://ec.europa.eu/health/documents/communityregister/2009/2009080362188/anx_6 2188_es.pdf</a>). Available from: <a href="http://cima.aemps.es/cima/pdfs/es/p/09539001/09539001_p.pdf">http://cima.aemps.es/cima/pdfs/es/p/09539001/09539001_p.pdf</a> [accessed 12.11.18]." ] ] ] 59 => array:3 [ "identificador" => "bib0775" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ …3] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0780" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medin.2016.11.007" "Revista" => array:6 [ …6] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0785" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/17482940701210179" "Revista" => array:6 [ …6] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0790" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.297.12.1319" "Revista" => array:6 [ …6] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0795" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0800" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of vaptans in the management of hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2013.01.034" "Revista" => array:6 [ …6] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0805" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vasopressin receptor antagonists in hyponatremia: uses and misuses" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0810" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inpatient hyponatraemia: adequacy of investigation and prevalence of endocrine causes" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0815" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2013-3032" "Revista" => array:6 [ …6] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0820" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid correction of severe hyponatremia with intravenous hypertonic saline solution" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0825" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ …3] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0830" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Urea for management of the syndrome of inappropriate secretion of ADH: a systematic review" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.endonu.2014.04.006" "Revista" => array:6 [ …6] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0835" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijcp.12713" "Revista" => array:6 [ …6] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0840" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ageing/31.2.151-a" "Revista" => array:6 [ …6] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0845" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebral salt wasting: truths, fallacies, theories, and challenges" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0850" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0855" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differentiating SIADH from cerebral/renal salt wasting: failure of the volume approach and need for a new approach to hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jcm3041373" "Revista" => array:6 [ …6] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib0860" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuous renal replacement therapy for the management of acid–base and electrolyte imbalances in acute kidney injury" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ackd.2016.02.005" "Revista" => array:6 [ …6] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0865" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful management of severe hyponatraemia during continuous renal replacement therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0870" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2014.01.451" "Revista" => array:6 [ …6] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0875" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correction of hyper and hyponatraemia during continuous renal replacement therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000369347" "Revista" => array:7 [ …7] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0880" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The urine/plasma electrolyte ratio: a predictive guide to water restriction" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0885" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Body water homeostasis: clinical disorders of urinary dilution and concentration" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2006030240" "Revista" => array:6 [ …6] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0890" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.03190807" "Revista" => array:6 [ …6] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0895" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of desmopressin acetate in severe hyponatremia in the intensive care unit" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.00950113" "Revista" => array:6 [ …6] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0900" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early relowering of serum sodium concentration overcomes disturbances in consciousness during hyponatremia overcorrection and prevents osmotic demyelination syndrome" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2169/internalmedicine.0299-17" "Revista" => array:6 [ …6] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib0905" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2011.08.020" "Revista" => array:6 [ …6] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib0910" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib0915" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib0920" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversal of transtentorial herniation with hypertonic saline" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000304042.05557.60" "Revista" => array:6 [ …6] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib0925" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib0930" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical practice. The syndrome of inappropriate antidiuresis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib0935" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia–hyponatremia in chronically psychotic patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib0940" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of euvolemic hyponatremia in the intensive care unit by urea" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc9292" "Revista" => array:5 [ …5] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib0945" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Crystalloids and colloids in critical patient resuscitation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medin.2014.12.007" "Revista" => array:6 [ …6] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib0950" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of hyponatremia and volume contraction" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12028-011-9585-9" "Revista" => array:6 [ …6] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack409902" "titulo" => "Acknowledgment" "texto" => "<p id="par0670" class="elsevierStylePara elsevierViewall">Thanks are due to Dr. Alberto Tejedor for his collaboration and contributions.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/21735727/0000004300000005/v1_201906010831/S2173572719300979/v1_201906010831/en/main.assets" "Apartado" => array:4 [ "identificador" => "77944" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Consensus Statement" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735727/0000004300000005/v1_201906010831/S2173572719300979/v1_201906010831/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572719300979?idApp=WMIE" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 22 | 14 | 36 |
2024 October | 158 | 73 | 231 |
2024 September | 165 | 70 | 235 |
2024 August | 167 | 94 | 261 |
2024 July | 158 | 83 | 241 |
2024 June | 170 | 110 | 280 |
2024 May | 232 | 104 | 336 |
2024 April | 177 | 71 | 248 |
2024 March | 190 | 68 | 258 |
2024 February | 124 | 67 | 191 |
2024 January | 172 | 58 | 230 |
2023 December | 212 | 80 | 292 |
2023 November | 199 | 125 | 324 |
2023 October | 237 | 95 | 332 |
2023 September | 225 | 71 | 296 |
2023 August | 151 | 61 | 212 |
2023 July | 160 | 58 | 218 |
2023 June | 242 | 54 | 296 |
2023 May | 179 | 91 | 270 |
2023 April | 144 | 40 | 184 |
2023 March | 201 | 67 | 268 |
2023 February | 172 | 41 | 213 |
2023 January | 181 | 44 | 225 |
2022 December | 180 | 44 | 224 |
2022 November | 196 | 80 | 276 |
2022 October | 202 | 68 | 270 |
2022 September | 164 | 70 | 234 |
2022 August | 166 | 64 | 230 |
2022 July | 173 | 87 | 260 |
2022 June | 176 | 72 | 248 |
2022 May | 233 | 86 | 319 |
2022 April | 288 | 62 | 350 |
2022 March | 297 | 109 | 406 |
2022 February | 321 | 54 | 375 |
2022 January | 281 | 77 | 358 |
2021 December | 219 | 117 | 336 |
2021 November | 278 | 88 | 366 |
2021 October | 254 | 114 | 368 |
2021 September | 227 | 51 | 278 |
2021 August | 260 | 101 | 361 |
2021 July | 221 | 84 | 305 |
2021 June | 279 | 66 | 345 |
2021 May | 313 | 110 | 423 |
2021 April | 606 | 190 | 796 |
2021 March | 406 | 94 | 500 |
2021 February | 346 | 57 | 403 |
2021 January | 346 | 76 | 422 |
2020 December | 404 | 63 | 467 |
2020 November | 198 | 44 | 242 |
2020 October | 219 | 46 | 265 |
2020 September | 400 | 51 | 451 |
2020 August | 368 | 81 | 449 |
2020 July | 406 | 74 | 480 |
2020 June | 407 | 60 | 467 |
2020 May | 461 | 68 | 529 |
2020 April | 542 | 79 | 621 |
2020 March | 583 | 74 | 657 |
2020 February | 898 | 83 | 981 |
2020 January | 680 | 90 | 770 |
2019 December | 561 | 74 | 635 |
2019 November | 82 | 36 | 118 |
2019 October | 20 | 10 | 30 |
2019 June | 5 | 1 | 6 |